BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20535004)

  • 21. Effect of Graves' disease and methimazole on warfarin anticoagulation.
    Busenbark LA; Cushnie SA
    Ann Pharmacother; 2006 Jun; 40(6):1200-3. PubMed ID: 16735660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Warfarin induced skin necrosis.
    Chan YC; Valenti D; Mansfield AO; Stansby G
    Br J Surg; 2000 Mar; 87(3):266-72. PubMed ID: 10718793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blue toe syndrome caused by cholesterol crystal embolisation in a patient with warfarin use.
    Kano Y; Shigehara Y
    BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37798039
    [No Abstract]   [Full Text] [Related]  

  • 24. Warfarin-related purple toes syndrome and cholesterol microembolization.
    Hyman BT; Landas SK; Ashman RF; Schelper RL; Robinson RA
    Am J Med; 1987 Jun; 82(6):1233-7. PubMed ID: 3605140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risks related with withholding and resuming anticoagulation in patients with non-variceal upper gastrointestinal bleeding while on warfarin therapy.
    Lee JK; Kang HW; Kim SG; Kim JS; Jung HC
    Int J Clin Pract; 2012 Jan; 66(1):64-8. PubMed ID: 22171905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of sulphasalazine potentiating the hypoprothombinemic effect of warfarin resulting in bleeding.
    Hall S; Rindone JP
    J Clin Pharm Ther; 2011 Apr; 36(2):246-8. PubMed ID: 21366655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
    Farraj RS
    Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracerebral hemorrhage associated with use of an imported medication.
    Haidar WN; Hoel RW; Takahashi PY
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):197-200. PubMed ID: 15561652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease.
    Levy DM; Silverman ED; Massicotte MP; McCrindle BW; Yeung RS
    J Rheumatol; 2005 May; 32(5):928-34. PubMed ID: 15868632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis.
    Warkentin TE; Whitlock RP; Teoh KH
    Am J Hematol; 2004 Jan; 75(1):56-62. PubMed ID: 14695634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible endotension associated with excessive warfarin anticoagulation.
    Iyer VS; Mackenzie KS; Corriveau MM; Steinmetz OK
    J Vasc Surg; 2007 Mar; 45(3):600-2. PubMed ID: 17321347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
    Ripley TL; Harrison D; Germany RE; Adamson PB
    Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation and treatment of patients with suspected normal pressure hydrocephalus on long-term warfarin anticoagulation therapy.
    Goodwin CR; Kharkar S; Wang P; Pujari S; Rigamonti D; Williams MA
    Neurosurgery; 2007 Mar; 60(3):497-501; discussion 502. PubMed ID: 17327794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nontraumatic intramural hematoma of the duodenum complicating warfarin therapy.
    Gutstein DE; Rosenberg SJ
    Mt Sinai J Med; 1997; 64(4-5):339-41. PubMed ID: 9293736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of warfarin in Christchurch for the treatment of venous thromboembolism.
    Egermayer P; Inder A; Town GI
    N Z Med J; 2001 Jul; 114(1136):336-8. PubMed ID: 11548101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics.
    White RH; McKittrick T; Takakuwa J; Callahan C; McDonell M; Fihn S
    Arch Intern Med; 1996 Jun; 156(11):1197-201. PubMed ID: 8639014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retropharyngeal hematoma as a complication of anticoagulation therapy.
    Akoğlu E; Seyfeli E; Akoğlu S; Karazincir S; Okuyucu S; Dağli AS
    Ear Nose Throat J; 2008 Mar; 87(3):156-9. PubMed ID: 18404913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of rectus sheath hematoma with antibiotic use and warfarin therapy: a case report.
    Kelly M; Moran J; Byrne S
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):266-9. PubMed ID: 16503323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warfarin-induced limb gangrene in the setting of lung adenocarcinoma.
    Klein L; Galvez A; Klein O; Chediak J
    Am J Hematol; 2004 Jun; 76(2):176-9. PubMed ID: 15164386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
    Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
    N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.